Versant Capital Management, Inc Spdr Ser Tr Spdr S&P Biotech E Transaction History

Versant Capital Management, Inc

  • $637 Million
  • Q2 2025

A detailed history of Versant Capital Management, Inc transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Versant Capital Management, Inc holds 900 shares of XBI stock, worth $76,230. This represents 0.01% of its overall portfolio holdings.

Number of Shares
900
Previous 1,800 50.0%
Holding current value
$76,230
Previous $151,000 50.99%
% of portfolio
0.01%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025
SELL
$69.8 - $85.28 $62,820 - $76,752
-900 Reduced 50.0%
900 $74,000
Q2 2023

Jul 10, 2023
SELL
$75.38 - $90.23 $67,842 - $81,207
-900 Reduced 33.33%
1,800 $149,000
Q1 2022

Apr 29, 2022
BUY
$81.07 - $115.44 $218,888 - $311,688
2,700 New
2,700 $243,000

Others Institutions Holding XBI

# of Institutions
844
Shares Held
108M
Call Options Held
17.7M
Put Options Held
28.5M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email